PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1483729
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1483729
Global OTC consumer health market is estimated to be valued at USD 211.91 Bn in 2024 and is expected to exhibit a CAGR of 4.2% during the forecast period (2024-2031).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 211.91 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 4.20% | 2031 Value Projection: | US$ 283.25 Bn |
Over-the-counter (OTC) medicines are drugs that are available without a prescription. Some OTC medicines are used to relieve aches, pains, and itches. Some prevent or cure diseases such as tooth decay and athlete's foot. Other OTC health products may help to manage recurring problems such as migraines and allergies. They are safe and effective when followed as directed by the directions on the label and as directed by a healthcare professional. Generic and brand name products for allergy, sinus, cold and flu, pain relief, home health care and daily living, support braces and wraps, dental and oral health, eye and ear care, first aid, smoking cessation, diabetes care, foot care, digestive health, incontinence, skin care, sleep aids, and vitamins are among the categories of covered OTC items. The benefits of using OTC over prescription drugs include easy accessibility, lower costs, convenience, and customer-empowering qualities. In turn, these factors contribute to increase adherence to therapy, with a positive impact on disease outcomes, healthcare costs and resource consumption.
Increasing inorganic activities such as agreements among market players is expected to drive growth of the global OTC consumer health market over the forecast period.
For instance, on January 24, 2022, Hindustan Foods Limited, a company manufacturing and selling nutritional food products and cereal based food products had signed a share purchase agreement with Reckitt Benckiser India Pvt. Ltd., a consumer goods company to acquire the entire issued Share Capital of Reckitt Benckiser Scholl India Private Limited (RBSIPL). The aim of this agreement was to mark Hindustan Foods Limited's entry into Over-the-counter (OTC) Healthcare and Wellness segment as a contract manufacturer.